nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A3—Irinotecan—pancreatic cancer	0.231	0.526	CbGbCtD
Norepinephrine—CYP1A2—Dacarbazine—pancreatic cancer	0.0682	0.155	CbGbCtD
Norepinephrine—CYP1A2—Tamoxifen—pancreatic cancer	0.0542	0.123	CbGbCtD
Norepinephrine—CYP1A2—Erlotinib—pancreatic cancer	0.0461	0.105	CbGbCtD
Norepinephrine—CYP1A2—Fluorouracil—pancreatic cancer	0.04	0.0909	CbGbCtD
Norepinephrine—Injection site necrosis—Gemcitabine—pancreatic cancer	0.034	0.175	CcSEcCtD
Norepinephrine—Gangrene—Gemcitabine—pancreatic cancer	0.0163	0.0839	CcSEcCtD
Norepinephrine—Hypovolaemia—Irinotecan—pancreatic cancer	0.0118	0.0607	CcSEcCtD
Norepinephrine—Lactic acidosis—Epirubicin—pancreatic cancer	0.00699	0.0359	CcSEcCtD
Norepinephrine—Lactic acidosis—Doxorubicin—pancreatic cancer	0.00647	0.0332	CcSEcCtD
Norepinephrine—Blood pressure increased—Sunitinib—pancreatic cancer	0.00445	0.0228	CcSEcCtD
Norepinephrine—Retrosternal pain—Epirubicin—pancreatic cancer	0.00424	0.0218	CcSEcCtD
Norepinephrine—Extravasation—Irinotecan—pancreatic cancer	0.0042	0.0216	CcSEcCtD
Norepinephrine—Extravasation—Gemcitabine—pancreatic cancer	0.00409	0.021	CcSEcCtD
Norepinephrine—Extravasation—Fluorouracil—pancreatic cancer	0.00402	0.0206	CcSEcCtD
Norepinephrine—Retrosternal pain—Doxorubicin—pancreatic cancer	0.00392	0.0201	CcSEcCtD
Norepinephrine—Photophobia—Fluorouracil—pancreatic cancer	0.00329	0.0169	CcSEcCtD
Norepinephrine—Extravasation—Docetaxel—pancreatic cancer	0.0029	0.0149	CcSEcCtD
Norepinephrine—Sweating—Tamoxifen—pancreatic cancer	0.00278	0.0143	CcSEcCtD
Norepinephrine—Blood pressure increased—Docetaxel—pancreatic cancer	0.00253	0.013	CcSEcCtD
Norepinephrine—Arrhythmia—Tamoxifen—pancreatic cancer	0.00233	0.012	CcSEcCtD
Norepinephrine—Arrhythmia—Erlotinib—pancreatic cancer	0.0023	0.0118	CcSEcCtD
Norepinephrine—Bradycardia—Sunitinib—pancreatic cancer	0.00227	0.0117	CcSEcCtD
Norepinephrine—Arrhythmia—Sunitinib—pancreatic cancer	0.00199	0.0102	CcSEcCtD
Norepinephrine—Sweating—Irinotecan—pancreatic cancer	0.00196	0.0101	CcSEcCtD
Norepinephrine—Hypertension—Tamoxifen—pancreatic cancer	0.00196	0.0101	CcSEcCtD
Norepinephrine—Extravasation—Epirubicin—pancreatic cancer	0.00196	0.0101	CcSEcCtD
Norepinephrine—Chest pain—Tamoxifen—pancreatic cancer	0.00193	0.00992	CcSEcCtD
Norepinephrine—Anxiety—Tamoxifen—pancreatic cancer	0.00192	0.00989	CcSEcCtD
Norepinephrine—Sweating—Gemcitabine—pancreatic cancer	0.00191	0.00982	CcSEcCtD
Norepinephrine—Chest pain—Erlotinib—pancreatic cancer	0.00191	0.00982	CcSEcCtD
Norepinephrine—Anxiety—Erlotinib—pancreatic cancer	0.0019	0.00978	CcSEcCtD
Norepinephrine—Bradycardia—Irinotecan—pancreatic cancer	0.00187	0.00961	CcSEcCtD
Norepinephrine—Extravasation—Doxorubicin—pancreatic cancer	0.00181	0.0093	CcSEcCtD
Norepinephrine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00179	0.00919	CcSEcCtD
Norepinephrine—Hypertension—Sunitinib—pancreatic cancer	0.00168	0.00862	CcSEcCtD
Norepinephrine—Chest pain—Sunitinib—pancreatic cancer	0.00165	0.0085	CcSEcCtD
Norepinephrine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00165	0.00848	CcSEcCtD
Norepinephrine—Arrhythmia—Irinotecan—pancreatic cancer	0.00164	0.00844	CcSEcCtD
Norepinephrine—Dyspnoea—Erlotinib—pancreatic cancer	0.00163	0.00839	CcSEcCtD
Norepinephrine—Arrhythmia—Gemcitabine—pancreatic cancer	0.0016	0.00822	CcSEcCtD
Norepinephrine—Arrhythmia—Fluorouracil—pancreatic cancer	0.00157	0.00808	CcSEcCtD
Norepinephrine—Dyspnoea—Sunitinib—pancreatic cancer	0.00141	0.00726	CcSEcCtD
Norepinephrine—Hypertension—Irinotecan—pancreatic cancer	0.00138	0.0071	CcSEcCtD
Norepinephrine—Hypertension—Gemcitabine—pancreatic cancer	0.00135	0.00691	CcSEcCtD
Norepinephrine—Chest pain—Gemcitabine—pancreatic cancer	0.00133	0.00682	CcSEcCtD
Norepinephrine—Chest pain—Fluorouracil—pancreatic cancer	0.00131	0.0067	CcSEcCtD
Norepinephrine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00126	0.00649	CcSEcCtD
Norepinephrine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00123	0.00632	CcSEcCtD
Norepinephrine—Vomiting—Tamoxifen—pancreatic cancer	0.00118	0.00605	CcSEcCtD
Norepinephrine—Vomiting—Erlotinib—pancreatic cancer	0.00116	0.00598	CcSEcCtD
Norepinephrine—Dyspnoea—Irinotecan—pancreatic cancer	0.00116	0.00598	CcSEcCtD
Norepinephrine—Headache—Tamoxifen—pancreatic cancer	0.00116	0.00596	CcSEcCtD
Norepinephrine—Headache—Erlotinib—pancreatic cancer	0.00115	0.00589	CcSEcCtD
Norepinephrine—Arrhythmia—Docetaxel—pancreatic cancer	0.00114	0.00583	CcSEcCtD
Norepinephrine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00113	0.00583	CcSEcCtD
Norepinephrine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00112	0.00573	CcSEcCtD
Norepinephrine—Vomiting—Sunitinib—pancreatic cancer	0.00101	0.00518	CcSEcCtD
Norepinephrine—Headache—Sunitinib—pancreatic cancer	0.000994	0.0051	CcSEcCtD
Norepinephrine—Hypertension—Docetaxel—pancreatic cancer	0.000955	0.00491	CcSEcCtD
Norepinephrine—Chest pain—Docetaxel—pancreatic cancer	0.000942	0.00484	CcSEcCtD
Norepinephrine—Sweating—Epirubicin—pancreatic cancer	0.000916	0.0047	CcSEcCtD
Norepinephrine—Bradycardia—Epirubicin—pancreatic cancer	0.000873	0.00448	CcSEcCtD
Norepinephrine—Sweating—Doxorubicin—pancreatic cancer	0.000847	0.00435	CcSEcCtD
Norepinephrine—Vomiting—Irinotecan—pancreatic cancer	0.000831	0.00427	CcSEcCtD
Norepinephrine—Headache—Irinotecan—pancreatic cancer	0.000818	0.0042	CcSEcCtD
Norepinephrine—Vomiting—Gemcitabine—pancreatic cancer	0.000809	0.00416	CcSEcCtD
Norepinephrine—Bradycardia—Doxorubicin—pancreatic cancer	0.000808	0.00415	CcSEcCtD
Norepinephrine—Dyspnoea—Docetaxel—pancreatic cancer	0.000805	0.00414	CcSEcCtD
Norepinephrine—Headache—Gemcitabine—pancreatic cancer	0.000797	0.00409	CcSEcCtD
Norepinephrine—Vomiting—Fluorouracil—pancreatic cancer	0.000796	0.00409	CcSEcCtD
Norepinephrine—Headache—Fluorouracil—pancreatic cancer	0.000784	0.00403	CcSEcCtD
Norepinephrine—Arrhythmia—Epirubicin—pancreatic cancer	0.000766	0.00393	CcSEcCtD
Norepinephrine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000709	0.00364	CcSEcCtD
Norepinephrine—Hypertension—Epirubicin—pancreatic cancer	0.000644	0.00331	CcSEcCtD
Norepinephrine—Chest pain—Epirubicin—pancreatic cancer	0.000635	0.00326	CcSEcCtD
Norepinephrine—Anxiety—Epirubicin—pancreatic cancer	0.000633	0.00325	CcSEcCtD
Norepinephrine—Hypertension—Doxorubicin—pancreatic cancer	0.000596	0.00306	CcSEcCtD
Norepinephrine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000589	0.00302	CcSEcCtD
Norepinephrine—Chest pain—Doxorubicin—pancreatic cancer	0.000588	0.00302	CcSEcCtD
Norepinephrine—Anxiety—Doxorubicin—pancreatic cancer	0.000586	0.00301	CcSEcCtD
Norepinephrine—Vomiting—Docetaxel—pancreatic cancer	0.000574	0.00295	CcSEcCtD
Norepinephrine—Headache—Docetaxel—pancreatic cancer	0.000566	0.00291	CcSEcCtD
Norepinephrine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000545	0.0028	CcSEcCtD
Norepinephrine—Dyspnoea—Epirubicin—pancreatic cancer	0.000543	0.00279	CcSEcCtD
Norepinephrine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000502	0.00258	CcSEcCtD
Norepinephrine—Vomiting—Epirubicin—pancreatic cancer	0.000387	0.00199	CcSEcCtD
Norepinephrine—Headache—Epirubicin—pancreatic cancer	0.000382	0.00196	CcSEcCtD
Norepinephrine—Vomiting—Doxorubicin—pancreatic cancer	0.000358	0.00184	CcSEcCtD
Norepinephrine—Headache—Doxorubicin—pancreatic cancer	0.000353	0.00181	CcSEcCtD
Norepinephrine—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	1.74e-05	4.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.74e-05	4.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	1.73e-05	4.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.72e-05	4.71e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.72e-05	4.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	1.72e-05	4.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.71e-05	4.67e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	1.7e-05	4.65e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.7e-05	4.64e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—pancreatic cancer	1.69e-05	4.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.68e-05	4.61e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTEN—pancreatic cancer	1.67e-05	4.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	1.67e-05	4.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.67e-05	4.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.67e-05	4.56e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	1.66e-05	4.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	1.65e-05	4.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.65e-05	4.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.64e-05	4.48e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.64e-05	4.48e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.64e-05	4.47e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	1.63e-05	4.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTEN—pancreatic cancer	1.63e-05	4.45e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.62e-05	4.44e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	1.62e-05	4.44e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.62e-05	4.44e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	1.62e-05	4.44e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.62e-05	4.43e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HRAS—pancreatic cancer	1.62e-05	4.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	1.61e-05	4.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.61e-05	4.4e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.6e-05	4.39e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	1.6e-05	4.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.6e-05	4.37e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	1.59e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	1.58e-05	4.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.58e-05	4.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.57e-05	4.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	1.57e-05	4.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.56e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	1.56e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.56e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTEN—pancreatic cancer	1.56e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.55e-05	4.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	1.55e-05	4.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	1.55e-05	4.23e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	1.54e-05	4.22e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—pancreatic cancer	1.54e-05	4.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	1.53e-05	4.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.53e-05	4.18e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	1.52e-05	4.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.52e-05	4.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.51e-05	4.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	1.51e-05	4.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1.51e-05	4.13e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	1.51e-05	4.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	1.5e-05	4.11e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.5e-05	4.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	1.5e-05	4.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.49e-05	4.09e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	1.49e-05	4.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	1.49e-05	4.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	1.48e-05	4.04e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	1.48e-05	4.04e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	1.47e-05	4.03e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.47e-05	4.03e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	1.47e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.47e-05	4.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	1.46e-05	4e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.46e-05	4e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	1.46e-05	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	1.46e-05	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.45e-05	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	1.45e-05	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	1.45e-05	3.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	1.44e-05	3.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	1.44e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	1.44e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	1.44e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.44e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	1.43e-05	3.92e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.43e-05	3.91e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—pancreatic cancer	1.43e-05	3.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	1.42e-05	3.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.42e-05	3.88e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.42e-05	3.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	1.41e-05	3.85e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	1.4e-05	3.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.4e-05	3.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	1.39e-05	3.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.38e-05	3.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	1.37e-05	3.76e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.37e-05	3.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	1.37e-05	3.74e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.36e-05	3.73e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—pancreatic cancer	1.36e-05	3.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	1.36e-05	3.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	1.35e-05	3.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	1.35e-05	3.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	1.34e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	1.34e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	1.34e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—pancreatic cancer	1.33e-05	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	1.33e-05	3.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	1.33e-05	3.63e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.33e-05	3.63e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.32e-05	3.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.32e-05	3.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.32e-05	3.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.31e-05	3.6e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	1.31e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.31e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.31e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	1.31e-05	3.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	1.31e-05	3.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	1.31e-05	3.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	1.3e-05	3.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	1.3e-05	3.55e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	1.3e-05	3.55e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	1.29e-05	3.52e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	1.28e-05	3.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.28e-05	3.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.28e-05	3.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.28e-05	3.49e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.27e-05	3.46e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.27e-05	3.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	1.26e-05	3.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	1.24e-05	3.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.24e-05	3.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	1.24e-05	3.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.23e-05	3.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	3.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.23e-05	3.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	1.23e-05	3.36e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—pancreatic cancer	1.22e-05	3.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.22e-05	3.34e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—pancreatic cancer	1.22e-05	3.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.22e-05	3.34e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	1.22e-05	3.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	1.22e-05	3.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	1.21e-05	3.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	1.21e-05	3.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	1.21e-05	3.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	1.21e-05	3.3e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.2e-05	3.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	1.2e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.2e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—pancreatic cancer	1.19e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	1.19e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	1.19e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	1.19e-05	3.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.19e-05	3.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.19e-05	3.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	1.18e-05	3.24e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	1.18e-05	3.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.18e-05	3.22e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	1.17e-05	3.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.16e-05	3.17e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.16e-05	3.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	1.15e-05	3.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	3.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.14e-05	3.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	1.14e-05	3.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.13e-05	3.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	1.13e-05	3.09e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	1.13e-05	3.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	1.13e-05	3.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	1.12e-05	3.06e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.11e-05	3.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	1.11e-05	3.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	1.11e-05	3.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	1.11e-05	3.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	1.11e-05	3.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	3.02e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	1.1e-05	3.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	1.1e-05	3.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.1e-05	3.02e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.1e-05	3.01e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	1.1e-05	3.01e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	1.1e-05	3.01e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	1.1e-05	3.01e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	1.09e-05	2.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.08e-05	2.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	2.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.06e-05	2.91e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.06e-05	2.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	2.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	1.05e-05	2.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	1.04e-05	2.86e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	1.04e-05	2.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.03e-05	2.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.03e-05	2.81e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.03e-05	2.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	2.8e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.02e-05	2.8e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	1.01e-05	2.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1e-05	2.74e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—pancreatic cancer	1e-05	2.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	9.98e-06	2.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	9.93e-06	2.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	9.88e-06	2.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	9.88e-06	2.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	9.85e-06	2.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	9.85e-06	2.7e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—pancreatic cancer	9.81e-06	2.68e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	9.68e-06	2.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	9.66e-06	2.64e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—pancreatic cancer	9.64e-06	2.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	9.59e-06	2.62e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	9.59e-06	2.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	9.5e-06	2.6e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	9.47e-06	2.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	9.44e-06	2.58e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	9.38e-06	2.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—pancreatic cancer	9.37e-06	2.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	9.32e-06	2.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	9.29e-06	2.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	9.28e-06	2.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	9.18e-06	2.51e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	9.16e-06	2.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	9.13e-06	2.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	9.13e-06	2.5e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—pancreatic cancer	8.98e-06	2.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	8.98e-06	2.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	8.88e-06	2.43e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	8.73e-06	2.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	8.7e-06	2.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	8.48e-06	2.32e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	8.47e-06	2.32e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	8.44e-06	2.31e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—pancreatic cancer	8.42e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	8.39e-06	2.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	8.39e-06	2.29e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	8.36e-06	2.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	8.28e-06	2.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	8.11e-06	2.22e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	8.05e-06	2.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	7.84e-06	2.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	7.79e-06	2.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	7.76e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	7.71e-06	2.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—pancreatic cancer	7.61e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	7.54e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTEN—pancreatic cancer	7.29e-06	1.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	7.21e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	7.11e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	6.85e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	6.37e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.14e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.2e-06	1.15e-05	CbGpPWpGaD
